[Clinical trial of a new derivative of the series of benzodiazepines: bromazepam (Ro 5-3350) in the treatment of phobic-obsessive symptoms].
D001552:Benzazepines / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy*; D010698:Phobic Disorders / Q000188:drug therapy*; D011602:Psychophysiologic Disorders / Q000188:drug therapy; D011725:Pyridines / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D001552:Benzazepines; D011725:Pyridines; D014149:Tranquilizing Agents
Sperimentazione clinica di un nuovo derivato della serie benzodiazepinica: il bromazepam (Ro 5-3350), nel trattamento dei sintomi fobico-ossessivi.